HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silencing of the gene for the alpha-subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4.

Abstract
CG is required for maintenance of the corpus luteum during pregnancy in higher primates. As CG is a heterodimeric molecule, some form of coordinated control must be maintained over the transcription of its two subunit genes. We recently found that expression of human CG beta-subunit (hCGbeta) in JAr human choriocarcinoma cells was almost completely silenced by the embryonic transcription factor Oct-3/4, which bound to a unique ACAATAATCA octameric sequence in the hCGbeta gene promoter. Here we report that Oct-3/4 is also a potent inhibitor of hCG alpha-subunit (hCGalpha) expression in JAr cells. Oct-3/4 reduced human GH reporter expression from the -170 hCGalpha promoter in either the presence or absence of cAMP by about 70% in transient cotransfection assays, but had no effect on expression from either the -148 hCGalpha or the -99 hCGalpha promoter. Unexpectedly, no Oct-3/ 4-binding site was identified within the -170 to -148 region of the hCGalpha promoter, although one was found around position -115 by both methylation interference footprinting and electrophoretic mobility shift assays. Site-directed mutagenesis of this binding site destroyed the affinity of the promoter for Oct-3/4, but did not affect repression of the promoter. Therefore, inhibition of hCGalpha gene transcription by Oct-3/4 appears not to involve direct binding of this factor to the site responsible for silencing. When stably transfected into JAr cells, Oct-3/4 reduced the amounts of both endogenous hCGalpha mRNA and protein by 70-80%. Oct-3/4 is therefore capable of silencing both hCGalpha and hCGbeta gene expression. We suggest that as the trophoblast begins to form, reduction of Oct-3/4 expression permits the coordinated onset of transcription from the hCGalpha and hCGbeta genes.
AuthorsL Liu, D Leaman, M Villalta, R M Roberts
JournalMolecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 11 Issue 11 Pg. 1651-8 (Oct 1997) ISSN: 0888-8809 [Print] United States
PMID9328347 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chorionic Gonadotropin, beta Subunit, Human
  • DNA-Binding Proteins
  • Fetal Proteins
  • Glycoprotein Hormones, alpha Subunit
  • HCFC1 protein, human
  • Homeodomain Proteins
  • Host Cell Factor C1
  • Neoplasm Proteins
  • Octamer Transcription Factor-1
  • Octamer Transcription Factor-2
  • Octamer Transcription Factor-3
  • POU2F1 protein, human
  • POU2F2 protein, human
  • POU5F1 protein, human
  • Repressor Proteins
  • Transcription Factors
Topics
  • Base Sequence
  • Binding Sites
  • Choriocarcinoma (pathology)
  • Chorionic Gonadotropin, beta Subunit, Human (biosynthesis, genetics)
  • Consensus Sequence
  • DNA Footprinting
  • DNA-Binding Proteins (pharmacology, physiology)
  • Female
  • Fetal Proteins (pharmacology)
  • Gene Expression Regulation, Developmental (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Glycoprotein Hormones, alpha Subunit (biosynthesis, genetics)
  • Homeodomain Proteins (pharmacology, physiology)
  • Host Cell Factor C1
  • Humans
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Neoplasm Proteins (biosynthesis, genetics)
  • Octamer Transcription Factor-1
  • Octamer Transcription Factor-2
  • Octamer Transcription Factor-3
  • Promoter Regions, Genetic
  • Regulatory Sequences, Nucleic Acid
  • Repressor Proteins (genetics, physiology)
  • Transcription Factors (pharmacology, physiology)
  • Transfection
  • Tumor Cells, Cultured (drug effects)
  • Uterine Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: